Product Description

🔹 Product Overview
Eugon-HP 150 IU Injection is a prescription fertility medicine containing Menotrophin 150 IU. Menotrophin is a highly purified combination of two naturally occurring reproductive hormones: follicle-stimulating hormone (FSH) and luteinizing hormone (LH).
It is used as part of fertility treatment in women who have problems with ovulation and may also be prescribed for selected men with infertility associated with inadequate gonadotropin production.

🔹 Key Uses
Eugon-HP 150 IU may be prescribed for:
Treatment of infertility associated with ovulation problems in women
Stimulation of ovarian follicles during fertility treatment
Use as part of assisted reproductive technology (ART), including IVF protocols
Treatment of selected cases of male infertility caused by hormonal deficiency
Supporting sperm production in men with appropriate hypogonadotropic conditions

🔹 Composition
Active ingredient: Menotrophin 150 IU
Hormonal components: FSH + LH
Dosage form: Powder for injection
Route: Intramuscular or subcutaneous injection, according to the prescribed product and treatment protocol
Therapeutic class: Gonadotropin / fertility medicine
Prescription status: Prescription medicine
Manufacturer/marketer: Samarth Life Sciences Pvt. Ltd.

🔹 How It Works
Eugon-HP 150 IU contains menotrophin, which provides FSH and LH activity.
In women, FSH stimulates the development and maturation of ovarian follicles, while LH contributes to normal ovarian function and reproductive hormone activity. This hormonal stimulation can help develop follicles in women with certain ovulatory disorders and during assisted fertility treatment.
In selected men with insufficient natural gonadotropin production, gonadotropin treatment can stimulate the testes and support testosterone production and sperm development.

🔹 Key Benefits
Supports follicular development in appropriate fertility-treatment protocols
Helps stimulate ovulation-related reproductive processes
Can be used as part of IVF and other assisted reproductive treatment
May support sperm production in appropriately selected men
Provides combined FSH and LH activity in an injectable formulation

🔹 Dosage and Administration
Eugon-HP 150 IU should be administered only according to a fertility specialist's prescription.
It is administered by injection, either into a muscle or under the skin according to the prescribed treatment protocol.
The dose and frequency vary considerably depending on the patient's age, sex, diagnosis, hormone levels, ovarian response, or sperm-production requirements.
In women, treatment generally requires monitoring of ovarian response, often including ultrasound and hormone testing.
Do not self-administer unless a qualified healthcare professional has specifically instructed you in the correct technique.
Do not change the dose or injection schedule yourself.
Important: The 150 IU strength does not represent a universal dose. Fertility-gonadotropin treatment must be individualized and medically monitored.

🔹 Possible Side Effects
Possible side effects may include:
Headache
Injection-site pain or irritation
Injection-site allergic reaction
Abdominal discomfort or bloating
Abdominal pain
Nausea
Breast tenderness
Acne
Sweating
In men, hormonal effects such as breast enlargement or changes in testosterone-related symptoms may occur
Serious Risk in Women
Gonadotropin treatment can cause ovarian hyperstimulation syndrome (OHSS). Symptoms can include significant abdominal swelling or pain, nausea, vomiting, rapid weight gain, and breathing difficulties.
Seek urgent medical attention if severe abdominal pain, marked abdominal swelling, difficulty breathing, or rapid unexplained weight gain occurs during fertility treatment.

🔹 Precautions
Eugon-HP 150 IU should be used only under specialist medical supervision.
Tell your doctor about any previous ovarian cysts or ovarian enlargement.
Inform your doctor if you have thyroid or adrenal disorders.
Patients with hormone-dependent cancers or certain reproductive-system abnormalities may require alternative treatment.
Women receiving gonadotropin therapy require monitoring to reduce the risk of excessive ovarian stimulation.
Multiple pregnancy can occur with fertility treatment.
Treatment should be discontinued or modified only according to the fertility specialist's instructions.
Tell your doctor about all medicines and fertility treatments you are currently receiving.
This medicine should not be used for weight loss or for non-prescribed hormone enhancement.